Chugai Pharmaceutical
4519.T
#314
Rank
HK$577.39 B
Marketcap
HK$350.88
Share price
-2.16%
Change (1 day)
-12.55%
Change (1 year)

Earnings for Chugai Pharmaceutical (4519.T)

Earnings in 2026 (TTM): HK$34.15 Billion

According to Chugai Pharmaceutical's latest financial reports the company's current earnings are HK$8.91 Billion. In 2025 the company made an earning of HK$31.30 Billion, an increase over its 2024 earnings that were of HK$27.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Chugai Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$34.15 B9.09%
2025 HK$31.30 B12.63%
2024 HK$27.79 B13.42%
2023 HK$24.50 B-23.15%
2022 HK$31.88 B9.05%
2021 HK$29.24 B32.48%
2020 HK$22.07 B47.49%
2019 HK$14.96 B72.71%
2018 HK$8.66 B27.68%
2017 HK$6.78 B25.22%
2016 HK$5.41 B-4.47%
2015 HK$5.67 B2.23%
2014 HK$5.54 B-8.93%
2013 HK$6.09 B-16.76%
2012 HK$7.32 B29.55%
2011 HK$5.65 B-6.25%
2010 HK$6.02 B-18.94%
2009 HK$7.43 B